Ghana: BLIS (UH3)

BLOODSAFE- Iron supplementation and nutritional counselling interventions to improve availability and safety of blood in Ghana - a Type I Pragmatic effectiveness - implementation hybrid trial

A mixed-methods study involving a randomized controlled trial among donors deferred for low haemoglobin within the catchment areas of the Southern Zonal Blood Centre in Ghana to evaluate the effectiveness and safety of six months of daily low dose iron supplementation (65mg elemental iron) compared to current standard of care to increase successful donation during 12-months follow-up. The UG3/UH3 BLIS studies are grounded in the RE-AIM implementation science framework.
Principal Investigators: Dr. Yvonne Dei Adomakoh & Dr. Lucy Asamoah-Akuoko identifier: NCT06101238